Patents Assigned to Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Instittue for Biomedical Research
  • Patent number: 7029877
    Abstract: There is provided a protease inhibitor and a method of inhibiting a protease selected from the group consisting of thrombin, chymotrypsin and neuropsin, by contacting the protease with an effective amount of a member of the phosphoethanolamine binding protein (PEBP) family.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: April 18, 2006
    Assignee: Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Instittue for Biomedical Research
    Inventors: Hugo Albrecht, Ulrich Hengst, Denis Monard